Quick reference guide of isolation
|
Abreviations |
|
|
|
C |
Contact isolation |
|
|
CN |
Culture negative x specified amount |
|
|
D |
Droplet precautions |
|
|
DE |
Decontamination of environment |
|
|
DH |
Duration of hospitalization |
|
|
DI |
Duration of Illness |
|
|
LC |
Lesions crusted |
|
|
A |
Airborne precautions |
|
|
S |
Standard precautions |
|
|
SAPP |
Special Administrative Policy and Procedure |
|
|
U |
Time specified in hours or days after initiation of effective antimicrobial therapy |
|
|
UR |
Time specified in days after onset of rash |
|
|
Us |
Time specified in days after onset of swelling |
|
|
INFECTION/CONDITION |
PRECAUTIONS |
|
|
TYPE |
DURATION |
|
|
Abscess |
|
|
|
-Draining, major |
S,C |
DI |
|
-Draining, minor or limited |
S |
|
|
Acquired immunodeficiency syndrome (AIDS) |
S |
|
|
Actinomycosis |
S |
|
|
Adenovirus infection |
|
|
|
-Conjunctivitis |
S,C |
DI |
|
-Disseminated ( 2 or more sites) infection in immunocompromised host |
S,C |
DI |
|
-Gastroenteritis |
S,C |
DI |
|
-Respiratory Infection |
S,D |
DI |
|
Amebiasis |
S |
|
|
Anthrax |
|
|
|
-Environmental aerosolizable spore containing powder * Until decontamination of environment complete. Persons decontaminating the area must wear N95 mask and protective clothing |
S,,C |
DE* |
|
-Cutaneous * * CP if contact with non-intact skin and with draining lesions |
S,C |
|
|
-Pulmonary |
S,C |
|
|
Antibiotic-associated colitis (see Clostridium difficile) |
_ |
_ |
|
Arthropod borne viral encephalitidis (eastern, western, Venezuelean equine encephalomyelitis; St. Louis, California encephalitis, West Nile Virus,dengue, yellow fever) |
S |
|
|
Ascariasis |
S |
|
|
Aspergillosis |
S |
|
|
Avian Influenza A (H5N1 Virus) |
S,A,C |
14 days after onset of symptoms |
|
Seasonal Influenza A or B ( H1N1 Virus ) |
S, D |
|
|
Babesiosis |
S |
|
|
Blastomycosis, North American, cutaneous or pulmonary |
S |
|
|
Botulism |
S |
|
|
Bronchiolitis (see respiratory infection in infants and young children) |
S, C |
DI |
|
Brucellosis (undulant, Malta, Mediterranean fever) |
S |
|
|
Cat-scratch fever (benign inoculation lymphoreticulosis) |
S |
|
|
Cellulitis, uncontrolled drainage |
S,C |
DI |
|
Chancroid (soft chancre) |
S |
|
|
Chickenpox (varicella) |
S,A,C |
DI/LC |
|
Chlamydia trachomatis |
|
|
|
-Conjunctivitis |
S |
|
|
-Genital (lymphogranuloma venerum ) |
S |
|
|
-Pneumonia ( infants ≤3 months old ) |
S |
|
|
Cholera (see gastroenteritis) |
C |
|
|
Closed-cavity infection |
|
|
|
-Draining, (limited or minor ) not draining |
S |
|
|
-Copious, uncontrolled drainage |
S,C |
|
|
Clostridium |
|
|
|
-C. Botulinum |
S |
|
|
-C. Difficile |
S,C |
U 48 hrs after diarrhea stops |
|
-C. Perfringens |
|
|
|
oFood poisoning |
S |
|
|
oGas gangrene |
S |
|
|
Coccidioidomycosis (valley fever) |
|
|
|
-Draining lesions |
S |
|
|
-Pneumonia |
S |
|
|
Colorado tick fever |
S |
|
|
Congenital rubella |
S,C |
Until 1 yr of age |
|
Conjunctivitis |
|
|
|
-Acute bacterial |
S |
|
|
-Chlamydia |
S |
|
|
-Gonococcal |
S |
|
|
-Acute Viral (acute hemorrhagic) |
S,C |
DI |
|
Corona Virus Associated with SARS (see SARS) |
|
|
|
-Human corona virus (229E, NL63, OC43) |
S,D |
|
|
-Middle east Respiratory Syndrome Corona Virus (MERS CoV) |
S,A,C |
|
|
Coxsackie virus disease (see enteroviral infection) |
|
|
|
Creutzfeldt-Jakob disease (CJD, VCJD) |
S |
|
|
Crimean- Congo Fever Virus |
S,C,D |
DI |
|
Croup (see respiratory infections in infants and young children) |
|
|
|
Cryptococcosis |
S |
|
|
Cryptosporidiosis (see gastroenteritis) |
|
|
|
Cysticercosis |
S |
|
|
Cytomegalovirus infection, neonatal or immunosuppressed |
S |
|
|
Decubitis ulcer, infected |
|
|
|
-Major |
S,C |
DI |
|
-Minor or limited |
S |
|
|
Dengue Fever |
S |
|
|
Diarrhea, acute -inefective etiology supsected (see gastroenteritis) |
|
|
|
Diphtheria |
|
|
|
-Cutaneous |
S, C |
CNx2* |
|
-Pharyngeal * Until 2 cultures taken 24 hours apart negative |
S, D |
CNx2* |
|
Ebola viral Hemorrhagic fever |
S, C,D |
DI/ SAPP |
|
Echinococcosis (hydatidosis) |
S |
|
|
Echovirus (see enteroviral infection) |
|
|
|
Encephalitis or encephalomyelitis (see specific etiologic agents) |
|
|
|
Endometritis |
S |
|
|
Enterobiasis (pinworm disease, oxyuriasis) |
S |
|
|
Enterococcus spp. (see multidrug-resistant organisms if epidemiologically significant or vancomycin resistant) |
|
|
|
Enterocolitis, Clostridium difficile |
S, C |
DI |
|
Enteroviral infections (group A & B coxackie and echo viruses- excluding polio virus) |
|
|
|
-Adults |
S |
|
|
-Infants and young children |
S,C |
DI |
|
Epiglottitis, due to Haemophilus influenza type b |
S,D |
U24Hrs |
|
Epstein-Barr virus infection, including infectious mononucleosis |
S |
|
|
Erythema infectiosum (also see parvovirus B19) |
D |
|
|
Escherichia coli gastroenteritis (see gastroenteritis) |
|
|
|
Food poisoning |
|
|
|
-Botulism |
S |
|
|
-Clostridium perfringens or Clostridium welchii |
S |
|
|
-Staphylococcal |
S |
|
|
Furunculosis-staphylococcal |
|
|
|
-Infants and young children |
S,C |
DI |
|
Gangrene (gas gangrene) |
S |
|
|
Gastroenteritis * * diapered or incontinent |
S,C
|
DI |
|
-Adenovirus |
S |
|
|
-Campylobacter spp. |
S |
|
|
-Cholera |
S,C |
DI |
|
-Clostridium difficile (See C. Difficile). Discontinue antibiotics if appropriate. Do not share electronic thermometers, ensure consistent environmental cleaning and disinfection using a Hypochlorite solution. Hand washing with soap and water preferred. |
S,C |
DI |
|
-Cryptosporidium spp. |
S |
|
|
-Escherichia coli |
|
|
|
oEnterohemorrhagic 0157:H7 |
S |
|
|
oOther species |
S |
|
|
-Giardia lamblia |
S |
DI |
|
-Noroviruses |
S |
|
|
-Rotavirus |
S,C |
DI |
|
-Salmonella spp. (inclduing S.typhi) |
S |
|
|
-Shigella spp. |
S |
|
|
oDiapered or incontinent |
S,C |
DI |
|
-Vibrio parahaemolyticus |
S |
|
|
-Viral (if not covered elsewhere) |
S |
|
|
-Yersinia enterocolitica |
S |
|
|
German measles (rubella) |
S,D |
URx7 |
|
Giardiasis (see gastroenteritis) |
|
|
|
Gonococcal ophthalmia neonatorum (gonorrheal ophthalmia, acute conjunctivitis of newborn) |
S |
|
|
Gonorrhoea |
S |
|
|
Granuloma inguinale (donovanosis granuloma ) |
S |
|
|
Guillain-Barre syndrome |
S |
|
|
Hand, foot, and mouth disease (see enteroviral infection) |
|
|
|
Hantavirus pulmonary syndrome |
S |
|
|
Helicobacter pylori |
S |
|
|
|
S, C, A |
DI/ SAPP |
|
Hepatitis, viral |
|
|
|
-Type A |
S |
|
|
oDiapered or incontinent patients |
S, C |
|
|
-Type B-HBsAg positive, acute or chronic |
S |
|
|
-Type C and other unspecified non-A, non-B |
S |
|
|
-Type E |
S |
|
|
oDiapered or incontinent patients |
S, C |
|
|
-Type G |
S |
|
|
Herpangina (see enteroviral infection) |
|
|
|
Herpes simplex (Herpesvirus hominis) |
|
|
|
-Encephalitis |
S |
|
|
-Neonatal * * For asymptomatic, exposed infants delivered vaginally or by C-section and if mother has active infection and membranes have been ruptured for more than 4 to 6 hours until infant surface cultures obtained at 24-36 hours of age negative after 48 hrs incubation |
S, C |
DI |
|
-Mucocutaneous,disseminated or primary, severe |
S, C |
DI |
|
-Mucocutaneous, recurrent (skin, oral, genital) |
S, C |
DI/LC |
|
Herpes Zoster (varicella-zoster)* *Non-immune staff should not enter room if immune caregivers are available. |
|
|
|
-Disseminated in any patient |
S, A, C |
|
|
-Localized in immunocompromised patient |
S, A, C |
DI/LC |
|
-Localized in normal patient |
S |
DI |
|
Histoplasmosis |
S |
|
|
Hookworm disease (ancylostomiasis, uncinariasis) |
S |
|
|
Human immunodeficiency virus (HIV) infection |
S |
|
|
Impetigo |
S, C |
U24Hrs |
|
Infectious mononucleosis |
S |
|
|
Influenza |
|
|
|
-Seasonal |
S, D |
DI |
|
-Emerging influenza viruses including Avian and others |
S,A,C |
DI |
|
-In immunocompromised patient |
SD |
DI |
|
Kawasaki syndrome |
S |
|
|
Lassa fever (see viral hemorrhagic fever) |
|
|
|
Legionnaires’ disease |
S |
DI |
|
Leprosy |
S |
|
|
Leptospirosis |
S |
|
|
Lice (pediculosis) |
S, C |
U 24Hrs |
|
Listeriosis |
S |
|
|
Lyme disease |
S |
|
|
Lymphocytic choriomeningitis |
S |
|
|
Lymphogranuloma venereum |
S |
|
|
Malaria |
S |
|
|
Marburg virus disease (see viral hemorrhagic fever) |
|
|
|
Measles (rubeola), all presentations |
S, A |
DI |
|
Melioidosis, all forms |
S |
|
|
Meningitis |
|
|
|
-Aseptic (nonbacterial or viral meningitis) (also see enteroviral Infections) |
S |
|
|
Infants and young children |
S,C |
|
|
-Bacterial, gram-negative enteric, in neonates |
S |
|
|
-Fungal |
S |
|
|
-Haemophilus influenzae type b, known or suspected |
S, D |
U24Hrs |
|
-Listeria monocytogenes |
S |
|
|
-Neisseria meningitidis (meningococcal)known or suspected |
S, D |
U24Hrs |
|
-Streptococcus Pneumoniae |
S |
|
|
-Tuberculosis (See Tuberculosis) |
S |
|
|
-Other diagnosed bacterial |
S |
|
|
Meningococcal Disease ( Sepsis, Pneumoniae, Meningitis) |
S, D |
U24Hrs |
|
Meningococcemia (meningococcal sepsis) |
S, D |
U24Hrs |
|
Methichillin Resistant Staphylococcus Aureus (MRSA) |
S, C |
|
|
Molluscum contagiosum |
S |
|
|
Monkeypox |
S,A,C |
LC |
|
Mucormycosis |
S |
|
|
Multidrug-resistant orgnaism, infection or colonization * (e.g MRSA, VRE, GNR) * Discontinue CP after consultation with the IP |
|
|
|
-Gastrointestinal |
S, C |
|
|
-Respiratory |
S, C |
|
|
-Skin, wound, or burn |
S, C |
|
|
Mumps (infectious parotitis ) |
S, D |
US9 days |
|
Mycobacteria, non-tuberculosis (atypical) |
|
|
|
-Pulmonary |
S |
|
|
-Wound |
S |
|
|
Mycoplasma pneumonia |
S, D |
DI |
|
Necrotizing enterocolitis |
S |
|
|
Nocardiosis, draining lesions, or other presentations |
S |
|
|
Orf Virus Disease |
S |
|
|
Parainfluenza virus infection, respiratory in infants and young children |
S, C |
DI |
|
Parvovirus B19 |
S, D |
DH |
|
Pediculosis (lice) |
S, C |
U24Hrs |
|
Pertussis (whooping cough) |
S, D |
U5DAYS |
|
Pharyngitis ( Streptococcus group A ) |
S, D |
U24Hrs |
|
Pinworm infection |
S |
|
|
Plague (Yersinia pestis) |
|
|
|
-Bubonic (without cough and chest x-ray negative) |
S |
|
|
-Pneumonic |
S, D |
U48 hours |
|
Pleurodynia (see enteroviral infection) |
|
|
|
Pneumonia |
|
|
|
-Adenovirus* |
S, D, C |
DI |
|
-Bacterial not listed elsewhere (including gram-negative bacterial) |
S |
|
|
-Burkholderia cepacia in cystic fibrosis patients, including respiratory tract colonization ** * Avoid placement in the same room with CF patients without B. cepacia |
S,C |
|
|
-Chlamydia |
S |
|
|
-Fungal |
S |
|
|
-Haemophilus influenzae, Type b |
|
|
|
oAdults |
S |
|
|
oInfants and children (any age) |
S, D |
U24Hrs |
|
-Legionella |
S |
|
|
-Meningococcal |
S, D |
U24Hrs |
|
-Mycoplasma (primary atypical pneumonia) |
S, D |
DI |
|
-Pneumocystis jiroveci ( carnii )* * Avoid placement in the same room with immunocompromised patient |
S |
|
|
-Streptococcus, group A |
|
|
|
oAdults |
S,D |
U24Hrs |
|
oInfants and small children |
S,D |
U24Hrs |
|
-Varicella zoster |
S,A |
DI |
|
Viral |
|
|
|
-Adults |
S |
|
|
-Infants and young children (see respiratory infectious disease, acute) |
|
|
|
Poliomyelitis ( Acute ) |
S,C |
DI |
|
Q fever |
S |
|
|
Rabies |
S |
DI |
|
Rat-bite fever (Streptobacillus moniliformis disease, Spirillum minus disease) |
S |
|
|
Relapsing fever |
S |
|
|
Respiratory infectious disease, acute (if not covered elsewhere) |
|
|
|
-Adults |
S |
|
|
-Infants and young children |
S,C |
DI |
|
Respiratory syncytial virus infection, in infants and young children, and immunocompromised adults * * In immunocompromised patients, extend the duration of contact precaution due to prolonged shedding. |
S, C |
DI |
|
Reye’s syndrome |
S |
|
|
Rheumatic fever |
S |
|
|
Rickettsial fevers, tickborne (Rocky Mountain spotted fever, tickborne typhus fever) |
S |
|
|
Rickettsialpox (vesicular rickettsiosis) |
S |
|
|
Ringworm (dermatophytosis, dermatomycosis, tinea) |
S |
|
|
Ritter’s disease (staphylococcal scalded skin syndrome) |
S,C |
DI |
|
Rocky Mountain spotted fever |
S |
|
|
Roseola infantum (exanthem subitum) |
S |
|
|
Rotavirus infection (see gastroenteritis) |
S,C |
DI |
|
Rubella (German measles) ( also see congenital rubella) |
S, D |
U7DAYS |
|
Rubeola |
S,A |
DI |
|
Salmonellosis (see gastroenteritis) |
S,C |
DI |
|
SARS (Severe Acute Respiratory Syndrome) * * Airborne precautions, preferred; D if AIIR not available. N95 or higher respiratory protection; surgical mask if N95 unavailable; eye protection (goggles, face shield); aerosol-generating procedures highest risk for transmission via small droplet nuclei and large droplets; vigilant disinfection. |
S,A,D,C |
DI |
|
Scabies |
S, C |
U24Hrs |
|
Scalded skin syndrome, staphylococcus (Ritter’s disease) |
S,C |
D,I |
|
Scarlet Fever |
S, C |
U24Hrs |
|
Schistosomiasis (bilharziasis) |
S |
|
|
Shigellosis (see gastroenteritis) |
|
|
|
Small Pox (variola) * * Non immune HCWs should not care when immune caregivers are available. N95 or higher respiratory protection forsusceptible and successfully vaccinated individuals; post exposure vaccine within 4 days of exposure for protection |
S,C,A |
DI |
|
Sporotrichosis |
S |
|
|
Spirillum minus disease (rat-bite fever) |
S |
|
|
Staphylococcal disease (S. aureus) |
|
|
|
-Pneumonia |
S |
|
|
-Skin, wound, or burn |
|
|
|
oMajor |
S, C |
DI |
|
oMinor or limited |
S |
|
|
oMRSA (see MRSA) |
|
|
|
Stretobacillus moniliformis disease (rat-bite fever) |
S |
|
|
Streptococcal disease (group A Streptococcus) |
|
|
|
-Skin, wound, or burn |
|
|
|
oMajor |
S, C |
U24Hrs |
|
oMinor or limited |
S |
|
|
-Endometritis (puerperal sepsis) |
S |
|
|
-Pharyngitis in infants and young children |
S, D |
U24Hrs |
|
-Pneumonia in infants and young children |
S, D |
U24Hrs |
|
-Scarlet fever in infants and young children |
S, D |
U24Hrs |
|
-Severe invasive disease (necrotizing fascitis, toxic shock syndrome) |
S,D |
U24Hrs |
|
Streptococcal disease (group B Streptococcus), neonatal |
S |
|
|
Streptococcal disease (not group A or B) unless covered elsewhere |
S |
|
|
Strongyloidiasis |
S |
|
|
Syphilis |
|
|
|
-Skin and mucous membrane, including congenital, primary, secondary |
S |
|
|
-Latent (tertiary) and seropositvity without lesions |
S |
|
|
Tapeworm disease |
|
|
|
-Hymenolepis nana (fish) |
S |
|
|
-Taenia solium (pork) |
S |
|
|
-Saginata (beef) |
S |
|
|
Tetanus |
S |
|
|
Tinea (fungus infection dematophytosia, dermatomycosis, ringworm) |
S |
|
|
Toxoplasmosis |
S |
|
|
Toxic shock syndrome (staphylococcal disease, Streptococcal desease) |
S |
|
|
Trachoma, acute |
S |
|
|
Trench mouth (Vincent’s angina) |
S |
|
|
Trichinosis |
S |
|
|
Trichomoniasis |
S |
|
|
Trichuriasis (whipworm disease) |
S |
|
|
Tuberculosis ( MycobacteriumTuberculosis) |
|
|
|
-Extrapulmonary ( no draining lesions, meningitis) |
S |
|
|
-Extrapulmonary ( Draining lesions ) * |
S, A, C |
|
|
-Pulmonary, confirmed or suspected or laryngeal disease * * Discontinue isolation (confirmed cases) when 14 days anti-TB therapy; 3 sputum smears negative for AFB; and, clinical improvement. Discontinue isolation (suspected cases) if patient has 3 sputum smears negative for AFB. |
S, A |
|
|
-Skin-test positive with no evidence of current pulmonary disease |
S |
|
|
Tularemia |
|
|
|
-Draining lesion |
S |
|
|
-Pulmonary |
S |
|
|
Typhoid (Salmonella typhi) fever (see gastroenteritis) |
|
|
|
Typhus, endemic and epidemic |
S,C |
DI |
|
Urinary tract infection (including pyelonephritis, with or without urinary catheter), except multi drug resistant organisms |
S |
|
|
Varicella (see chickenpox) |
|
|
|
Vibrio parahaemolyticus (see gastroenteritis) |
|
|
|
Vincent’s angina (see trench mouth) |
|
|
|
Viral Hemorrhagic Fevers (refer to policy) ( Lassa, Ebola, Marburg, Crimean-Congo fever viruses) |
S,C,D |
DI |
|
Viral Respiratory disease |
|
|
|
-Adults |
S |
|
|
-Infants and young children (see respiratory infectious disease, acute) |
|
|
|
Whooping cough (see pertussis) |
S, D |
U5DAYS |
|
Wound infections |
|
|
|
-Major |
S, C |
DI |
|
-Minor or limited |
S |
|
|
Yersinia enterocolitica gastroenteritis (see gastroenteritis) |
|
|
|
Zoster (varicella-zoster), shingles (see chicken pox) |
|
|
|
-Disseminated in any patient |
S, A, C |
DI/LC |
|
-Localized in immunocompromised patient |
S, A, C |
DI/LC |
|
-Localized in normal patient |
S |
|
|
Zygomycosis (phycomycosis, mucormycosis) |
S |
|
© - 2020 - Infection and Control Department. http://ictraining.net/